The absence of systematic screening for cardiac amyloidosis, particularly wild‐type transthyretin amyloidosis in elderly patients, limits our ability to determine whether RASP reflects myocardial fibrosis, amyloid infiltration, or a combination of both. The gene discussed is TTR; the disease is Myocardial fibrosis.